Despite underperforming the market over the past year, Medtronic still enjoys fairly upbeat outlook from analysts.

Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A ...

The pharma company's newer immunology drugs, Skyrizi and Rinvoq, have delivered robust sales growth that's proving to be the ...

Medtronic (NYSE: MDT) announced that Gregory L. Smith, EVP, enterprise operations, notified the company of his decision to ...

Press Release  Medical technology leader, Medtronic has successfully concluded the UK leg of its European ACM2U Truck ...

Alexander Zverev's mother, Irina Zvereva, recently opened up about the player's battle with Type 1 diabetes since he was four ...

PCSK9 inhibition may be a suitable alternative for statin-intolerant patients, and recent data demonstrated its efficacy as ...

The CGM market is an exciting, fast-growing, multibillion-dollar medtech sector, according to our new Medtech Market ...

A bioadaptor implant adaptable to vessel physiology was linked to less target lesion failure and target vessel failure ...

Dick Cheney, a powerful and controversial former vice president, has died. These are some of his most memorable career ...

As the health care industry continues to evolve, disputes are becoming increasingly complex, from reimbursement matters and ...

LVHD offers a 3.3% dividend yield, outpacing most peers, but its total returns and Sharpe ratio have lagged the broader ...